Treatment options in moderate and severe depression: Decision analysis supporting a clinical guideline

British Journal of Psychiatry

Volumn 189, Issue DEC., 2006, Pages 494-501

  Simon, Judit ^a,b   Pilling, Stephen ^b   Burbeck, Rachel ^c   Goldberg, David ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL COLLEGE OF PSYCHIATRISTS   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DISEASE SEVERITY; DRUG COST; HEALTH CARE COST; HUMAN; MEDICAL DECISION MAKING; PATIENT CARE; PRACTICE GUIDELINE; PSYCHOTHERAPY; QUALITY OF LIFE; RELAPSE; REMISSION; TREATMENT OUTCOME; UNITED KINGDOM;

ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DEPRESSIVE DISORDER; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; PRACTICE GUIDELINES; TREATMENT OUTCOME;

EID: 33845343611     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.bp.105.014571     Document Type: Article

References (35)

1. Blackburn, I. M., Bishop, S., Glen, A. I. M., et al (1981) The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. British Journal of Psychiatry, 139, 181-189.
2. Blackburn, I. M., Euson, K. & Bishop, S. (1986) A 2-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. Journal of Affective Disorders, 10, 67-75.
3. Bollini, P., Pampallona, S., Tibaldi, G., et al (1999) Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials. British Journal of Psychiatry, 174, 297-303.
4. Borghi, J. & Guest, J. F. (2000) Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK. European Psychiatry, 15, 378-387.
5. Briggs, A. H. & Gray, A. M. (1999) Handling Uncertainty When Performing Economic Evaluation of Healthcare Interventions. Health Technology Assessment, vol. 3, no. 2 (http://www.hta.nhsweb.nhs.uk/fullmono/mon302.pdf).
6. Briggs, A. H. & Sculpher, M. (1995) Sensitivity analysis in economic evaluation of health care technologies: the role of sensitivity analysis. Health Economics, 4, 355-372.
7. Briggs, A. H., Goeree, R., Blackhouse, G., et al (2002) Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Medical Decision Making, 22, 290-308.
8. British Medical Association & Royal Pharmaceutical Society of Great Britain (2003) British National Formulary (March issue). London & Wallingford: BMJ Books & Pharmaceutical Press.
9. Department of Health (2003) Prescription Cost Analysis: England 2002. London: Department of Health (http://www.dh.gov.uk/assetRoot/04/06/13/53/ 04061353.pdf).
10. DerSimonian, R. & Laird, N. (1986) Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177-188.
11. Elkin, I., Shea, M.T., Watkins, J., et al (1989) National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Archives of General Psychiatry, 46, 971-982.
12. Fawcett, J., Epstein, P., Fiester, S. J., et al (1987) Clinical management - imipramine/placebo administration manual. NIMH Treatment of Depression Collaborative Research Program. Psychopharmacological Bulletin, 23, 309-324.
13. Freemantle, N., House, A., Song, F., et al (1994) Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide. BMJ, 309, 249-253.
14. Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56-62.
15. Hautzinger, M., de Jong-Meyer, R., Treiber, R., et al (1996) Efficacy of cognitive behaviour therapy, pharmacotherapy, and the combination of both in non-melancholic, unipolar depression [in German]. Zeitschrift für Klinische Psychologie, 25, 130-145.
16. Hedges, L. V. & Olkin, I. (1985) Statistical Methods for Meta-analysis. Orlando, FL: Academic Press.
17. Higgins, J. P. T. & Thompson, S. G. (2002) Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21, 1539-1558.
18. Keller, M. B., McCullough, J. P., Klein, D. N., et al (2000) A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine, 342, 1462-1470.
19. Knapp, M. & Ilson, S. (2002) Economic aspects of depression and its treatment. Current Opinion in Psychiatry, 15, 69-75.
20. Kupfer, D. J. (1991) Long-term treatment of depression. Journal of Clinical Psychiatry, 52 (suppl. 5), 28-34.
21. McCullough, J. P. (1995) Therapist Manual for Cognitive Behavioural Analysis System of Psychotherapy. Richmond, VA: Virginia Commonwealth University.
22. Miller, I. W., Norman, W., Keinter, G., et al (1989) Cognitive-behavioral treatment of depressed inpatients. Behavior Therapy, 20, 25-47.
23. Murphy, G. E., Simons, A. D., Wetzel, R. D., et al (1984) Cognitive therapy and pharmacotherapy singly and together in the treatment of depression. Archives of General Psychiatry, 41, 33-41.
24. National Collaborating Centre for Mental Health (2005) Depression: Management of Depression in Primary and Secondary Care. National Clinical Practice Guideline 23. London: British Psychological Society & Gaskell.
25. National Depression Campaign (1999) National Depression Campaign Survey. London: National Depression Campaign.
26. National Institute for Clinical Excellence (2004) Depression: Management of Depression in Primary and Secondary Care. Clinical Guideline 23. London: NICE.
27. Netten, A. & Curtis, L. (2002) Unit Costs of Health and Social Care. Canterbury: Personal Social Services Research Unit.
28. Netten, A. & Curtis, L. (2003) Unit Costs of Health and Social Care. Canterbury: Personal Social Services Resaerch Unit.
29. Revicki, D. A. & Wood, M. (1998) Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications. Journal of Affective Disorders, 48, 25-36.
30. Richardson, G., Wonderling, D., Simons, J., et al (2004) Incorporating health economics in guidelines and assessing resource impact. In Guideline Development Methods: Information for National Collaborating Centres and Guideline Developers, pp. 8/1-8/6. London: NICE.
31. Scott, C., Tacchi, M. J., Jones, R., et al (1997) Acute and one-year outcome of a randomised controlled trial of brief cognitive therapy for major depressive disorder in primary care. British Journal of Psychiatry, 171, 131-134.
32. Scott, J., Palmer, S., Paykel, E., et al (2003) Use of cognitive therapy for relapse prevention in chronic depression. Cost-effectiveness study. British Journal of Psychiatry, 182, 221-227.
33. Simons, A. D., Murphy, G. E., Levine, J. L., et al (1986) Cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry, 43, 43-48.
34. Thomspon, L. W., Coon, D. W., Gallagher-Thompson, D., et al (2001) Comparison of desipramine and cognitive/behavioural therapy in the treatment of elderly outpatients with mild-to-moderate depression. American Journal of Geriatric Psychiatry 9, 225-240.
35. World Health Organization (2001) World Health Report 2001: Mental Health: New Understanding, New Hope. Geneva: WHO.